![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-desktop-header-1gif-4289.gif)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-mobgif-81230.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/29/2890248/0/en/Metagenomi-to-Present-at-the-2024-Jefferies-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/05/14/2881881/0/en/Metagenomi-Presents-Data-at-Scientific-Conferences-and-First-Quarter-2024-Financial-Results.html
https://www.globenewswire.com/news-release/2024/05/01/2873588/0/en/Metagenomi-to-regain-full-development-rights-to-its-wholly-owned-base-editing-and-RIGS-systems.html
https://www.prnewswire.com/news-releases/clinical-microbiomics-launches-advanced-long-read-16s-its-18s-isolate-and-metagenomics-sequencing-services-302124618.html
https://www.globenewswire.com/news-release/2024/04/08/2859156/0/en/Metagenomi-to-Present-at-Upcoming-Scientific-Meetings.html
https://www.globenewswire.com/news-release/2024/03/27/2853262/0/en/Metagenomi-Reports-Business-Updates-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/13/2828682/0/en/Metagenomi-Announces-Closing-of-Initial-Public-Offering.html
https://www.fiercebiotech.com/biotech/metagenomi-telomir-head-nasdaq-morning-double-test-case-preclinical-ipos-2024
https://www.globenewswire.com//news-release/2024/02/09/2826539/0/en/Metagenomi-Announces-Pricing-of-Initial-Public-Offering.html